Brief: Chromadex Entered Into An Amendment To Business Financing Agreement On Dec. 8

Niagen Bioscience

13/12/2023 22:02

Dec 13 (Reuters) - Chromadex Corp  CDXC.O :
    * CHROMADEX CORP - ON DECEMBER 8, ENTERED INTO AN AMENDMENT
TO
BUSINESS FINANCING AGREEMENT
    * CHROMADEX CORP - CREDIT AGREEMENT PROVIDES FOR A REVOLVING
CREDIT LINE OF UP TO $10.0 MILLION
    * CHROMADEX CORP - AMENDMENT EXTENDED MATURITY DATE OF
REVOLVING
CREDIT LINE UNDER CREDIT AGREEMENT TO NOVEMBER 12, 2025

Further company coverage:  CDXC.O 

 ((Reuters.Briefs@thomsonreuters.com;))